Second line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspective

Emily A. Kendall, Ted Cohen, Carole D. Mitnick, David W. Dowdy

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Second line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspective'. Together they form a unique fingerprint.

Medicine & Life Sciences